In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Becton Dickinson and Oncogene Science sign 5 yr. contract

Executive Summary

Becton Dickinson and Oncogene Science have signed a five-year contract to jointly fund development of the RAS, NEU and EGF oncogenes and the p53 anti-oncogene cancer diagnostics. This is the second agreement signed by the two companies.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Alliance
    • Manufacturing or Supply
    • R+D and Marketing-Licensing

Related Companies